Comparison between Ganga Pharmaceuticals IPO and OFS Technologies IPO.
Ganga Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while OFS Technologies IPO is a SME Fixed Price proposed to list at BSE SME.
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | First Overseas Capital Ltd. | V.B.Desai Financial Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Alacrity Securities Ltd. | VCK Share & Stock Broking Services Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.45 Cr whereas the issue size of the OFS Technologies IPO is up to ₹4.02 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of OFS Technologies IPO is ₹25.00 per share.
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹15.00 per share | ₹25.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 8000 shares | 6000 shares |
| Fresh Issue Size | 9,68,000 shares | 16,08,000 shares |
| Fresh Issue Size (Amount) | up to ₹1.45 Cr | up to ₹4.02 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 9,68,000 shares | 16,08,000 shares |
| Issue Size Total (Amount) | up to ₹1.45 Cr | up to ₹4.02 Cr |
Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while OFS Technologies IPO opens on Dec 28, 2015. The closing date of Ganga Pharmaceuticals IPO and OFS Technologies IPO is Feb 09, 2016, and Dec 31, 2015, respectively.
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2016 | Dec 28, 2015 |
| Issue Close | Feb 09, 2016 | Dec 31, 2015 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Feb 22, 2016 | Jan 14, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Ganga Pharmaceuticals IPO P/E ratio is , as compared to OFS Technologies IPO P/E ratio of .
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 91.05 | 99.98 |
| Promoter Shareholding (Post-Issue) | 68.09 | 73.43 |
| P/E Ratio | ||
| Market Cap | ₹60.92 Cr. | ₹16.04 Cr. |
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 1.27 | 20.44 |
In the Ganga Pharmaceuticals IPO Retail Individual Investors (RII) are offered 5,12,000 shares while in OFS Technologies IPO retail investors are offered 5,12,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Ganga Pharmaceuticals IPO and in OFS Technologies IPO.
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 56,000 shares | 96,000 shares |
| QIB | 0 shares | |
| NII | 5,12,000 shares | 8,04,000 shares |
| RII | 5,12,000 shares | 8,04,000 shares |
| Employee | 0 shares | |
| Others | ||
| Total | 10,24,000 shares | 16,08,000 shares |
Ganga Pharmaceuticals IPO subscribed 1.09x in total, whereas OFS Technologies IPO subscribed 2.57x.
| Ganga Pharmaceuticals IPO | OFS Technologies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.16x | 1.86x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.03x | 3.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.09x | 2.57x |
